Enjoy complimentary customisation on priority with our Enterprise License!
The nephrostomy devices market size is forecast to increase by USD 75.4 million, at a CAGR of 4.5% between 2023 and 2028. The market is witnessing significant growth due to the increasing incidence of kidney stone disease, which is a major indication for the use of these wearable devices. Miniaturized Percutaneous Nephrostolithotomy (PCNL) procedures are gaining popularity as they help reduce bleeding and pain during kidney stone disease treatment. In addition, the market is expected to grow significantly due to the rising healthcare expenditure and the increasing number of clinical studies on urolithiasis treatment. However, the market is also faced with challenges such as complications associated with nephrostomy tube placement and maintenance, including infection, tube blockage, and leakage. Additionally, the high cost of these devices and the need for skilled healthcare professionals to perform the procedures can hinder market growth. Despite these challenges, the market is expected to continue growing due to the high prevalence of kidney stones and the ongoing development of advanced nephrostomy devices to address the complications associated with their use.
The nephrostomy devices market refers to the segment of medical devices used for the treatment of various kidney disorders, including Urolithiasis, Hydronephrosis, and Urinary tract obstruction. These devices are primarily used for draining urine from the kidneys, especially when the normal flow is obstructed due to conditions like kidney stones, tumors, or chronic ailments. The market for nephrostomy devices includes products like nephrostomy catheters, guidewires, sheath dilators, and drainage tubes. The market is driven by the increasing prevalence of kidney disorders, the growing number of minimally invasive surgical procedures, and the rising healthcare spending. Ambulatory surgical centers and hospitals are the major end-users of these devices. In a recent clinical study, the effectiveness of a new catheter stabilizer was evaluated for use in minimally invasive surgeries. This medical device aims to enhance patient outcomes by improving the precision and stability of catheters during procedures. Other factors contributing to the market growth include the increasing number of patient visits for urolithiasis treatment and the growing trend of medical tourism.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024 to 2028, as well as historical data from 2018 to 2022 for the following segments.
The guidewires segment is estimated to witness significant growth during the forecast period. Nephrostomy devices, including nephrostomy catheters and guidewires, play a crucial role in managing various kidney disorders such as urolithiasis, hydronephrosis, and kidney cancer. Minimally invasive surgical procedures, such as percutaneous nephrostomy, have gained popularity due to their effectiveness in treating kidney diseases and reducing post-operative infections. Major vendors like Cook Medical and Cardinal Health offer customization options for nephrostomy catheters and sheath dilators to cater to diverse clinical needs. Guidewires, an essential component of these procedures, are available in two basic configurations: solid steel or nitinol core wires and coiled or braided wires. They offer benefits such as flexibility, pushability, and kink resistance.
Get a glance at the market share of various regions Download the PDF Sample
The guidewires segment was valued at USD 120.30 million in 2018. In some cases, the visualization of guidewires under fluoroscopic X-ray imaging is not feasible, leading vendors to coat guidewires with radiopaque markers to improve visibility. Technological advances continue to drive the market, with minimally invasive procedures like percutaneous nephrostomy becoming increasingly common for urolithiasis treatment, urinary tract infections, and other kidney disorders. Lifestyle-related disorders, such as diabetes, and the growing geriatric population contribute significantly to the healthcare expenditure on kidney diseases. Clinical studies are ongoing to further improve patient outcomes and reduce complications associated with nephrostomy procedures.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The market has witnessed significant growth due to the increasing prevalence of urinary tract obstructions, tumors, and chronic kidney diseases. These conditions necessitate the use of medical devices such as drainage tubes and sheath dilators for proper treatment. Healthcare spending on nephrology and urology procedures has been on the rise, leading to an increase in patient visits to hospitals and clinics. Nephrostomy devices are essential in managing these conditions, providing effective drainage, and facilitating diagnostic procedures. The market is expected to continue its growth trajectory, driven by the increasing demand for minimally invasive procedures and the expanding healthcare infrastructure.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The increasing incidence of kidney stone disease is notably driving market growth. Kidney stones, crystalline concentrations of minerals formed in the kidney or urinary tract, affect approximately 120,000 people per million worldwide. This condition, also known as urolithiasis, impacts individuals of all ages, sexes, and races, with a higher prevalence among men aged 20-49 years. The incidence of kidney stones has risen in both developed and developing countries, with a higher lifetime risk observed in the Middle East and Western nations. Nephrostomy devices, including catheters, guidewires, nasal dilators, and drainage tubes, play a crucial role in managing kidney stones and associated conditions such as hydronephrosis, urinary tract infections, and post-operative infections.
Minimally invasive surgical procedures, such as percutaneous nephrostomy, have gained popularity due to their effectiveness and reduced recovery time. Technological advances in urological instruments, including endourological instruments and minimally invasive procedures, have significantly improved patient outcomes. Customization options cater to various kidney diseases, including kidney cancer, bladder cancer, prostate cancer, and diabetes. Ambulatory surgical centers and medical tourism have made these procedures more accessible and affordable. Despite these advancements, complications such as infection and bleeding remain concerns. The global healthcare expenditure on kidney stone treatment and related disorders continues to rise, underscoring the importance of ongoing research and innovation in this field. Thus, such factors are driving the growth of the market during the forecast period.
Miniaturized PCNL to reduce bleeding and pain in kidney stone disease treatment is the key trend in the market. Nephrostomy devices, including nephrostomy catheters and urological guidewires, play a crucial role in managing various kidney disorders, such as urolithiasis, hydronephrosis, and kidney cancer. Miniaturized versions of percutaneous nephrostomy (PCNL) procedures, like mini PCNL, have been developed to address the limitations of standard PCNL, such as invasiveness, increased risk of hemorrhage, greater postoperative pain, and longer hospital stays. In mini PCNL, smaller incisions and instruments are used, resulting in reduced procedural morbidity and complications, including trauma, pain, blood loss, and infection. This leads to a shorter length of hospital stay.
This device is particularly beneficial for treating kidney diseases, including kidney stones, diabetes, and chronic ailments, in the geriatric population and those with lifestyle-related disorders. Technological advances have led to the development of customization options for nephrostomy catheters, drainage tubes, sheath dilators, and endourological instruments, enhancing patient outcomes in minimally invasive surgical procedures for urological conditions, such as bladder cancer, ovarian cancer, prostate cancer, urinary tract infections, and post-operative infections in ambulatory surgical centers and medical tourism destinations. Thus, such trends will shape the growth of the market during the forecast period.
Complications associated with nephrostomy devices is the major challenge that affects the growth of the market. Nephrostomy devices, including catheters, guidewires, sheath dilators, and drainage tubes, are essential medical instruments used in the treatment of various kidney and urological disorders, such as kidney stones, urolithiasis, hydronephrosis, and chronic kidney diseases. These minimally invasive surgical instruments are increasingly being used in ambulatory surgical centers and medical tourism destinations due to technological advances and improved patient outcomes. Nephrostomy catheters, in particular, play a crucial role in the treatment of kidney stones, urinary tract infections, and post-surgical drainage. However, their use is not without risks, including hemorrhage, tube dislodgement, tube blockage, tube leakage, fever, damage to adjacent structures, vascular injury, and catheter-associated urinary tract infections (CAUTI). Diabetes patients undergoing nephrostomy procedures are at a higher risk of postoperative complications. Improper reuse and reprocessing of devices can also lead to infections.
According to the Centers for Disease Control and Prevention (CDC), approximately 75% of urinary tract infections acquired in hospitals are associated with urinary catheters. Minimally invasive procedures, such as percutaneous nephrostomy, have gained popularity due to their effectiveness in treating kidney stones, kidney diseases, and urological cancers, including bladder, ovarian, and prostate cancer. Lifestyle-related disorders and the geriatric population are other significant factors driving the growth of the market. Hence, the above factors will impede the growth of the market during the forecast period
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
B.Braun SE - The company offers nephrostomy devices such as Nephrofix, and Nephrofix Certo.
The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
In addition, the market is expected to grow significantly due to the rising healthcare expenditure and the increasing number of clinical studies on urolithiasis treatment. Ambulatory surgical centers and medical tourism have also contributed to the growth of the market. The market is competitive, with companies focusing on innovation and customization to meet the specific needs of patients and healthcare providers. Urinary tract infections and patient outcomes are critical factors influencing the market.
Market Scope |
|
Report Coverage |
Details |
Page number |
167 |
Base year |
2023 |
Historic period |
2018 - 2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 4.5% |
Market Growth 2024-2028 |
USD 75.4 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
4.24 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 37% |
Key countries |
US, Denmark, China, Canada, and India |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Amecath, AngioDynamics Inc., Argon Medical Devices Inc., B.Braun SE, Balton Sp. z o.o., Becton Dickinson and Co., Blueneem Medical Devices Pvt. Ltd., Boston Scientific Corp., Cardinal Health Inc., Coloplast AS, Cook Group Inc., Envaste Ltd., Meditech Devices Pvt. Ltd., Olympus Corp., ROCAMED, and Teleflex Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for market forecast period |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.